Biomarkers for the diagnosis of Alzheimer’s disease The characteristic symptoms of Alzheimer’s disease, such as progressive memory loss or other cognitive deficits and behavioral disorders, can make us suspect the diagnosis of this disease. This suspicion can be supported by the determination of biomarkers. Biomarkers measure the biological changes that occur in the brains of … Read moreHow do Alzheimer’s biomarkers change over time?
Non-fibrillar amyloid-β (Aβ) plaques are considered to be a critical component of Alzheimer’s disease. Characterization of these species comes mainly from studies in cellular or animal models, but there is little data in intact human samples due to the lack of adequate optical microscopic resolution to study these small structures. Marta Querol-Vilaseca in collaboration with … Read moreSuper-resolution is here for amyloid plaques
The behavioral variant of frontotemporal dementia is a neurodegenerative syndrome characterized by a progressive personality change. Given that patients maintain their cognitive abilities relatively intact in the early stages of the disease, the diagnosis requires both a thorough clinical evaluation and biomarkers to support the diagnosis of a neurodegenerative disease. Ignacio Illán Gala and Victor … Read moreIn our recent publication, we analyze cortical microstructure in frontotemporal dementia
Dr. Ignacio Illán-Gala has been selected as one of the “Atlantic Fellows” of the Global Brain Health Institute (GBHI) in 2019. The objective of this program, coordinated by the University of California San Francisco and Trinity College Dublin, is to promote brain health globally by training a network of future leaders in brain health. The … Read moreDr. Illán-Gala has been selected as an “Atlantic Fellow” in the GBHI program
Obesity and Alzheimer It has been established that middle-age obesity is a risk factor for Alzheimer’s disease, but the results from studies in older people are contradictory. Our recent study would explain the discrepancies on this topic. This work is the result of a collaborative effort between the Neuroimage team of the Sant Pau Memory … Read moreIs obesity a risk factor for Alzheimer’s disease?
The Instituto de Salud Carlos III (Institute of Health Carlos III) has awarded subvention grants to four research projects submitted by the Sant Pau Memory Unit in the 2018 call for Health Research and Development Strategy in the modality of Proyectos de Investigación en Salud (Health Research Projects). This is an annual national competitive call that … Read moreThe Instituto de Salud Carlos III awards subvention grants to four projects of the Sant Pau Memory Unit